Foresite Capital Fund III L.P. 13D/13G Filings for CymaBay Therapeutics, Inc. (CBAY)

Foresite Capital Fund III L.P. 13D and 13G filings for CymaBay Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
10:41 am
Sale
2020-12-31 13G CymaBay Therapeutics, Inc.
CBAY
Foresite Capital Fund III L.P. 3,428,898
5.000%
-390,828decrease
(-10.23%)
Filing